Hyperproduction of the type IV plasmid-encoded dihydrofolate reductase was studied in Escherichia coli J62-2 (pUKll23). Hyperproduction of the enzyme was shown to occur not simply as a response to a given concentration of trimethoprim but also to the presence of thymidine in the medium. Before hyperproduction occurred the bacteria began to elongate and die, thus showing the symptoms of thymine starvation. Hyperproduction also required the presence of L-methionine, adenine and glycine, suggesting that the elevated production of the enzyme was a response to the ability of trimethoprim to starve the cell of thymine metabolites.
Introduction
Trimethoprim selectively inhibits bacterial dihydrofolate reductase (5,6,7,8-tetrahydrofolate : NADP+ oxidoreductase EC 1 .5.1.3) which catalyses the reduction of dihydrofolate to tetrahydrofolate. This deprives the cell of an essential co-factor for the biosynthesis of purines, pyrimidines and amino acids.' Several mechanisms of resistance to trimethoprim have been reported, the most common being the plasmid-encoded production of an additional trimet hoprim-resis t an t di h ydro fola te reduc t ase that enables the trimethoprim blockade of the chromosomal enzyme to be by-passed.' To date, 14 plasmidmediated dihydrofolate reductases have been identified from sequence and biochemical data. [3] [4] [5] Of these, the type IV enzyme is unique, as it is the only plasmidmediated dihydrofolate reductase for which the specific activity of the enzyme is dependent on the concentration of trimethoprim.6 Although hyperproduction of the Escherichia coli chromosomal dihydrofolate reductase is well documented as a resistance mechanism,'^* this has been shown only once to be the result of induction rather than constitutive high-level produ~tion.~
The type IV dihydrofolate reductase, which was identified in strains isolated in South India in 1984, confers only partial trimethoprim resistance." The MIC of trimethoprim for the host strain is dependent on the test medium and resistance is only moderate even in optimum conditions, despite the high levels of dihydrofolate reductase that can be achieved.l* ~ Received 22 Jan. 1992; revised version received 28 Aug. 1992; accepted 4 Sept. 1992.
In this study we examined the physiological response of E. coli harbouring a plasmid producing type IV dihydrofolate reductase and considered the role of dihydrofolate reductase production in trimethoprim resistance.
Materials and methods

Bacterial strains and plasmids
All experiments were performed with E. coli strain J62-2 (pUK1123), an E. coli transconjugant containing the original plasmid isolated from a clinical strain in 1984.
Culture media
The complex medium used for exposure to trimethoprim was IsoSensitest Broth (Oxoid) ; the solid medium used was Diagnostic Sensitivity Test Agar (DSTA; Oxoid). These media were chosen because neither contain significant amounts of thymine derivatives that would affect the action of trimethoprim." Thymidine (Sigma) and trimethoprim (Wellcome Research Foundation, Crewe) were added as required. Davis-Mingioli medium12 supplemented with glucose, L-proline, L-histidine, L-tryptophan, L-methionine, adenine and glycine, as required, was used as the minimal. medium. cultures of bacteria grown with vigorous agitation at 37°C in the appropriate medium. The cells were harvested by centrifugation (6000 g for 10 min at 15°C) and resuspended in buffer A (50 mM sodium phosphate, pH 7.4, containing 10 mM /3-mercaptoethanol and 1 mM EDTA). The bacteria were disrupted by sonication and the cell debris was removed by centrifugation (40000 g for 60 min at 4°C). Dihydrofolate reductase activity was assayed-at 37°C in 40 mM sodium phosphate buffer, pH 6, as described previously.2 One unit of dihydrofolate reductase activity was defined as the amount of enzyme required to reduce 1 nmol of dihydrofolate/min. The specific activity was determined by measuring the protein concentration in each cleared lysate by the method of Waddell.13
Enzyme preparation and assay
Efect of trimethoprim and thymidine on dihydrofolate reductase expression
A series of cultures of E. coli 562-2 (pUK1123) in 250ml of IsoSensitest broth was challenged with increasing concentrations of trimethoprim or with trimethoprim 40 mg/L and increasing concentrations of thymidine (0-50 mg/L). The cells were harvested after 20 h at 37°C and disrupted by sonication. The specific activity of dihydrofolate reductase was measured as described above.
Efect of trimethoprim on viable count and cell morphology
E. coli 562-2 (pUK1123) was inoculated directly from a DSTA plate into two flasks containing 250 ml of IsoSensitest broth, with and without trimethoprim 40mg/L. The flasks were incubated at 37°C and shaken vigorously for 24 h. At time 0 and every 4 h thereafter, a viable count and Gram's stain was performed on the bacteria in each flask. In a separate experiment, cultures were exposed to trimethoprim 40mg/L in the presence and absence of thymidine 2 mg/L and examined over a 24-h period in a similar way.
The role of L-methionine, glycine and adenine on enzyme expression
E. coli 562-2 (pUKll23) was challenged in Davis-Mingioli minimal medium supplemented with glucose 2.8 mg/L and the auxotrophic requirements for this strain (L-proline, L-histidine and L-tryptophan, each at 50 mg/L). Different combinations of L-methionine, adenine and glycine (50 mg/L of each) were also added. The effects of challenge with trimethoprim were monitored as before, but 1-L cultures were used to compensate for the slower growth rates and the lower bacterial yield in minimal medium. The highest concentration of trimethoprim that promoted high levels of dihydrofolate reductase production in E. coli J62-2 (pUK1123) without diminishing the final recovery of bacteria was 40mg/L (table I) . Challenge with trimethoprim 80 or 160 mg/L gave higher specific activities but the final cell counts were considerably reduced. For this reason the concentration of trimethoprim used in subsequent experiments was 40 mg/L. Induction of high levels of the chromosomal dihydrofolate reductase sufficient to produce trimethoprim resistance in regulatory mutant strains of E. coli occurs within 3 min of exposure to trimethoprim.' In contrast, when E. coli 562-2 (pUKll23) was challenged with trimethoprim 40 mg/L, elevated levels of dihydrofolate reductase could not be detected for 5-14 h (table 11). Although it was unclear what changes were taking place in the bacteria during this lag period, it was assumed that no growth could occur, since elevated levels of dihydrofolate reductase were not synthesised. 
Concentration of thymidine
Efect of thymidine
In sensitive E. coli strains, cell elongation in response to trimethoprim occurs in metabolic conditions similar to those of "thymineless death". Inhibition of the chromosomal dihydrofolate reductase results in the prevention of thymidine monophosphate synthesis and, therefore, DNA synthesis; however, it does not affect Protein synthesis which is essential for death resulting from thymine star~ati0n.l~ To investigate whether thymineless conditions are required for the trimethoprim-induced synthesis of the type IV dihydrofolate reductase, production of the enzyme was investigated in the presence of thymidine. A thymidine concentration of 2 mg/L was sufficient to allow bacteria to grow without inducing dihydrofolate reductase production (table 111) . Furthermore, bacteria cultured in IsoSensitest broth and challenged with trimethoprim in the presence of thymidine did not show a decrease in viable count ( fig.  3 ) and microscopy revealed no cell elongation. These results suggest that thymine starvation may be an important trigger for the hyperproduction of the type IV dihydrofolate reductase. To investigate this, the production of the enzyme was examined in minimal medium. Earlier studies had demonstrated that the MIC of trimethoprim for E. coli J62-2 (pUK1123) was dependent on the presence of glycine, L-methionine and adenine," three compounds that are central to the thymidine pathway and to the action of trimeth0~rim.l~
In minimal medium, enzyme hyperproduction occurred only when L-methionine, adenine and glycine were all present. When any of these compounds was absent, the bacteria were able to grow in the presence of trimethoprim 40 mg/L without producing high levels of dihydrofolate reductase (table IV) . When all three were present, little growth occurred after 24 h although the bacteria produced high levels of dihydrofolate reductase. Microscopy revealed greatly elongated bacteria; but when the cultures were reincubated for a further 12 h, growth occurred and the bacteria returned to normal size. Thus, when all three supplements were present (i.e., in conditions favouring " thymineless death ") the situation mimicked what was happening over a longer time scale in complex medium.
As expected, in the presence of all three supplements, a thymidine concentration of 2 mg/L allowed growth in the absence of elevated levels of dihydrofolate reductase despite a trimethoprim concentration of 40 mg/L.
Hyperproduction of the type IV dihydrofolate reductase occurred only under conditions promoting " thymineless death ", which results from continued cell metabolism in the absence of a balanced synthesis of normal DNA. 1 4 3 l5 Morphologically, " thymineless death" is characterised by a marked increase in bacterial length and volume. 16 Trimethoprim and other inhibitors of dihydrofolate reductase bring about " thymineless death " by disrupting the equilibrium between tetrahydrofolate and other tetrahydrofolate co-factor forms;14$ however, this has been observed previously only in trimethoprim-sensitive bacteria that do not possess plasmid-encoded dihydrofolate reductases. A thymineless state can also occur through depletion of tetrahydrofolate in the presence of pools of purines and amino acids adequate for growth. 14* l 5
Clearly a given concentration of trimethoprim is not enough to cause hyperproduction of the type IV dihydrofolate reductase; rather, increased synthesis of the type IV enzyme seems to be an adaptation to conditions present during " thymineless death ". Induction of enzymes as a response to "thymineless death " has been reported previo~s1y.l~ We propose that once sufficient type IV enzyme has been produced, trimethoprim blockade can be overcome by the increased number of trimethoprim binding sites and the bacteria can resume growth. This mechanism of resistance whereby trimethoprim inhibition is overcome by production of large quantities of enzyme, rather than by synthesis of an inherently resistant dihydrofolate reductase, is similar to the chromosomal type of resistance. Indeed partial sequence analysis of the type IV dihydrofolate reductase reveals it to be closely related to the E. coli chromosomal enzyme."
